Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Link to Nevada SOS documents:
https://www.dropbox.com/s/ztzfydhpbkl2y2j/Telefix_NV_SOS_docs_RS_Redacted.pdf?dl=0
Do you want one?? Give me 20 minutes or so...
Yes.
I requested copies of the documents (last 3) including the 3 page amendment and 2 corrections from the Nevada SOS. Cost me $10 via credit card and it took about 6 hours for them to send them to me via email.
1. Amendment states a 1:500 reverse split.
2. Changes the effective date from Dec 30 to Jan 15.
3. Corrects the split ration from 500 to 100.
Therefore at 5:01pm Eastern time tomorrow (1/15), a 1:100 reverse split will be enacted. The share price will open Monday at 100x the share price and my position will be cut by 100x.
The long- term consequences of this can be debated. One thought is that the split will be used in conjunction with a reverse merger (Telefix Technologies). Then the extra shares can be used to raise capital down the road.
Another thought might be that r/s done so that an ownership interest by VZ can be established.
The R/S would make the O/S only 4.8 million with a float of about 1.4 Million. They haven't diluted over the last several years, so I am not sure they would now. The CEO would just be taking a big hit as she owns 61M shares pre split and 610k after.
If the SaaS users can start providing some revenue, there is "potential" for $3-4 million a month.
Just have to request a copy of whichever documents you want from the Nevada SOS.
It should cost $2 a page and less than 24 hours. Can send request and receive documents via email.
I can virtually guarantee that this trades at least $.05 next week.
It was on the bottom of one of the slides, she didn't mention it.
On Mezaun's ppt presentation at CEO boot camp it said $40-185.
I would guess $75 average or so since not everybody gets the Cadillac. $75x 40k users is $3MM a month or $36 MM per year.
Depending on the revenue multiple, one can calculate a potential share price. Emphasis on the word potential.
3 pages. That is more than an increase in a/s.
Spin off and IPO with a tax free distribution of stock perhaps?? That would be ideal. Need some customers though.
IMO an increase in a/s would be half a paragraph on a single page. Look at the SOS forms for other companies and notice the a/s increases are all short, short.
There is probably 500 posters at each poster session during SABCS. No exaggeration. A huge exhibition hall where everybody walks around. Presenter just stands by the poster waiting for questions. Usually just small talk from the viewers.
Not sure I really need any more but pretty tempting down in the 7-8 range.
Just noticed on the tape..
Each of the last 3 days there were tape paints for 7 shares, 250 shares, and 160 shares. Somebody is trying real hard to keep this price down. WTF
Publication Number: P2-11-02 Title: Robust generation of T cell immunity to HER2 in HER2+ breast cancer patients with a degenerate subdominant HLA-DR epitope vaccine Knutson K, Kalli K, Block M, Hobday T, Padley D, Erskine C, Dockter T, Suman V, Wilson G, Degnim A. Mayo Clinic Jacksonville, FL; Mayo Clinic Rochester, MN; Mayo Clinic Rochester, MN; Mayo Clinic Rochester, MN; Mayo Clinic Rochester, MN; TapImmune, Inc. Seattle, WA; Mayo Clinic Rochester, MN Body: Background: Recent studies have indicated that vaccination can protect against cancer development. One key aspect of developing vaccines is circumventing peripheral tolerance by identifying subdominant epitopes that are unique to the deregulated tumor microenvironment. While existing subdominant epitope vaccines are showing efficacy in preventing cancer, these vaccines are applicable only for subsets of patients with specific HLA subtypes. Therefore, we recently developed a degenerate HER2 subdominant epitope-based vaccine that should be useful in approximately 85% of all patients. The vaccine consists of a pool of four HLA-DR-restricted 15-amino acid epitopes (p59, p88, p422, and p885) that are naturally processed and are designed to elicit helper T cell immunity, the cornerstone of immune surveillance. Here we present Phase I trial results of this multi-peptide HER2 vaccine. Methods: Eligible women had HER2+ breast cancer (Stages II-III) and had completed standard treatment (i.e. surgery, chemotherapy, and trastuzumab) at least 90 days prior to enrollment and were rendered disease free. Vaccine included the above epitope pool along with adjuvant GM-CSF. Patients were vaccinated six times over six months and were monitored for toxicity at each visit. Peripheral blood samples were collected for immune responses evaluating for T cell and antibody immunity. Endpoints were safety and immunogenicity leading to the development CD4 helper T cells that recognized naturally-processed HER2. Results: Twenty-two subjects (age 33 to 69 years) were enrolled. At the present analysis, 21 have completed all 6 vaccination cycles; one patient withdrew after developing a grade 1 injection site reaction during the first vaccination cycle. Twenty patients have had LVEF measured after vaccination; only 2 patients had an LVEF drop of 10% or more but remained in the normal LEVF range. One severe toxicity was reported: a grade 3 INR increase considered unrelated to treatment. Mild to moderate (grade 1-2) toxicities included injection site reactions, fatigue, and white blood cell count decreases. All patients were alive at analysis and only one experienced a recurrence (median follow-up 507 days, range 22 - 844). Twenty patients have had immune response assessments. Vaccine induced T cell immunity was observed in 94% of patients to p59, in 94% of patients to p88, in 82% of patients to p422, and in 74% of patients to p885. Importantly, T cell immunity to naturally processed HER2 proteins occurred in 94% of patients. The mean number of T cells specific for each peptide, post vaccination, ranged from 349-528 T cells per million peripheral blood mononuclear cells (PBMCs). The mean number of T cells specific for whole HER2 protein was 783 T cells per million PBMCs compared to a mean of 898 T cells/million PBMCs specific for the foreign tetanus toxin. In contrast to T cell responses, modestly increased antibody immunity to HER2 occurred in 35% of patients, consistent with the T cell-inducing design of the vaccine. Conclusion: Our results show that it is possible to develop vaccines with broad HLA coverage that circumvent natural tolerance and induce tumor antigen-specific immunity in the vast majority of patients.
Nice pickup whoever it was!!
Should be neutral to beneficial if done right.
The subsidiary "Telefix Technologies" can do an equity carve out or IPO based on the new reg A+ amendment. This cash serves as capital infusion for growth and could pay off some debt of the parent.
All this is predicated on having revenue in order to make the spin off attractive to investors. That has been the real issue all along.
Anybody else have thoughts?
The subsidiary is going to use them from the current O/S...
Shares need to come from somewhere.
Husband has always been with the company. Daughter is intern (new)
40,000 users?!?!
How much do companies pay for SaaS subscription? Even if $50 a year for subscription we are looking at 2MM in revenue.
At $200 per sub it is more like 8MM
The Company references the amount it expects to recognize from new and repeat
data connectivity subscribers with VPP partnership to meet a contractual requirement of 40,000 users
annually each year. In addition, the company references the amount of revenue it expects to recognize with
sales of licenses along with new and repeat subscribers for its SaaS solution. These are two vital cash flow
streams to add to the Company’s asset base.
No $$ amount given
The Company was later awarded a Vertical Solution
Partnership contract in April 2015, which provides us the connectivity for the solution using the most
expansive LTE (4G) network at discounted rates.
We want this solution to advance industries across multiple verticals and improve lives. The
Company is in the process of a product roll-out. This will be a license and subscription based Software as
a Service (Saas) platform.
Surprise...report is up on OTC. Have fun with this one!!
It's an annual so 90 days. I am wrong. I thought it was just a Q but that is 45 days so wrong either way.
Hopefully some valuable info when we do see it.
Think we'll get the Notification of Late Filing tonight or will the notification itself be late?
My bet is a week late as per usual.
Everything is right there in B&W. Read the filings. Three things are almost certainly going to happen. Probably not in the order they are written down.
Be patient...the evidence is too convincing. IMO
Sorry, I guess not. I suppose I was recalling this statement from Lee at the last CC just prior to Q&A:
"I’d like to add that since our year-end conference call is coinciding with the close of the first quarter as Tracie said, we’ll not have a conference call when we announced the final funding. We will have our next conference call when we announce the final funding of the Niger agreement for the trucks or the end of the second quarter whichever happens to come first."
Agreed. Just hang tight to Aug 17.
Didn't Lee say on the last CC that they were not going to make any Niger announcement until the next Q end CC?
Have to check my notes.
GLTA
322k @ 15:07:26
Must be a T form. Price= 0.0111
Yep. Both directions though.
Ask 831,274@.0018
100,000@.0019
27,900@.0035
70,000@.0045
10,000@.01
Bid 58,000@.0015
75,000@.0014
10,000@.0010
10,000@.0005
Hey big shot why don't you clear them now?? Only 224k on the ask at .0018??
20% what?
Actually $229.35...its just small talk.
More sales into the bid than bought at the ask and still up 20% on only 115,000 share volume. Love it.
NITE has an endless supply of .0012 it seems.
Impatient retail seller?
Which do you think we will see first?
1) CC and webcast(?) re-scheduled or 2) Annual Report/notification of late filing. Due Sept 15.
It's getting bad. Even I am getting restless. Not selling though...
I am not responsible for your lack of conviction to hold this and be patient. I have never said this is the next AAPL, but I fortunately have the luxury to not have to flip penny stocks on a gain of .0001 for a living. I got into pennys as a hobby instead of buying sports cars and stupid stuff like that. I can afford to wait this out and if I lose money oh well, I had fun listening to all moronic clowns on this board with the exception of a few. Entertainment fee nothing more.
I wear nothing but big boy pants and have backed that up with my purchases of this stock. I am not included in the "we" of which you speak as the basis for my first 20MM shares is .0008. And have selectively added since then. Last time I checked, I am ahead and will continue to be ahead.
Everybody here thanks you for the vanishing act. Let's see if you actually do that or if you are full of hot air in every aspect...TLFX
Common sense replies
1. R/S talk started 6 months prior to VZ announcement. SOunds like contingent plan if deal doesn't pan out. If R/S planned, why put it on 3 Q reports and not just do it.
2. VZ relationship confirmed by Stefanski/Tarrant. PR states Vertical Solutions Provider with co-marketing
3. They were finally responding prior to all the FB/TWTR trolls.
4. There have also been times when people have been sitting at the desks and had a conversation with visitors (TXinvestor)
5. I have personally received an email from the company
6. PR on postponement states adding webcast in addition. Takes some time.
7. Old symbol with different mgmt and bought as a relatively clean shell.
8. Used to show revenue when they were focused on tower work, but changing business plans can set a company back in the rev dept.
9. Does it not work?? I could care less it it were written in crayon. The info is just outdated.
10. Does one expect Dallas to be Atlantis and permanently flooded?
Other (my) facts:
1. payroll taxes owed have increased YOY due to hiring
2. Several private investors have loaned money (see $250,000 cash infusion)
3. Several investors have bought 20-100k of shares in the company as Rule 504 shares
4. If you have been watching the share volume, there has been no dumping/dilution (see number 3) which would be indicative of a so-called scam.
5. no fluff PR's to drum up support (see number 4)
6. Recognition by VZ innovation award makes the current VZ partnership very, very likely
7. Strobel and Heikenfeld
8. CC was certainly planned with a real CC phone number and everything. Can't control the weather 3-4 in advance.
9. O/S have not changed in almost 2 years
10. In April 15, 2013 Q report they told us what they were up to. "The company is in the early stages of implementing a proprietary cloud based back-office infrastructure, new improved financial/operational controls,
recruiting, hiring, training and equipping tower crews, technical and engineering workforce, installing a technical command center, and increasing its management team and advisory boards. The company feels this strategy, while being heavy on front load costs, will prove to be beneficial in meeting both the company’s long-term profitability goals as opposed to the short term, and that of their customers."
3000 shares. A whole $4.80 in stock.
How many shares are you looking to buy...TLFX
Actually my decimal point got me...it's only 286k. There is only 424k showing on L2 below $200.
I should put a market order in for 45 and see if it's real